Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI
Efficacy of Intracoronary Infusion of Different Medicine With Targeted Perfusion Catheter on Myocardial Perfusion in Patients With STEMI Undergoing Primary PCI:an Open,Prospective,Randomized,Multicenter Trial.
Sponsor: RenJi Hospital
Listed as NCT03252665, this PHASE4 trial focuses on ST Segment Elevation Myocardial Infarction and remains ongoing. Sponsored by RenJi Hospital, it has been updated 7 times since 2017, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Sep 2019 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Not Yet Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Sep 2019 [monthly]
Not Yet Recruiting PHASE4
-
Sep 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- RenJi Hospital
- Ruijin Hospital
- Shanghai 10th People's Hospital
- Shanghai 6th People's Hospital
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .